A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients

NCT07694973 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
62
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University